Gadopentetate Dimeglumine versus Ultrasmall Superparamagnetic Iron Oxide for Dynamic Contrast-enhanced MR Imaging of Tumor Angiogenesis in Human Colon Carcinoma in Mice

Radiology

Volumn 229, Issue 2, 2003, Pages 429-438

  De Lussanet, Quido G ^a   Backes, Walter H ^a   Griffioen, Arjan W ^a   Van Engelshoven, Jos M A ^a   Beets Tan, Regina G H ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Angiogenesis; Animals; Contrast media, comparative studies; Magnetic resonance (MR), contrast media; Magnetic resonance (MR), relaxometry; Neoplasms, blood supply; Neoplasms, experimental studies

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CARCINOMA; COMPARTMENT MODEL; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; EXPERIMENTAL MODEL; HISTOLOGY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; KINETICS; MICROVASCULATURE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR BLOOD FLOW;

ANIMALS; CARCINOMA; COLONIC NEOPLASMS; CONTRAST MEDIA; GADOLINIUM DTPA; IRON; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, NUDE; MICROCIRCULATION; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; OXIDES;

EID: 0142147988     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2292021007     Document Type: Article

References (36)

1. Folkman J. Angiogenesis research: from laboratory to clinic. Forum (Genova) 1999; 9:59-62.
2. Griffioen AW, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 2000; 52:237-268.
3. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncoiogy: current status and future directions. J Magn Reson Imaging 2002; 16:407-422.
4. Taylor JS, Tofts PS, Port R, et al. MR imaging of tumor microcirculation: promise for the new millennium. J Magn Reson Imaging 1999; 10:903-907.
5. Daldrup H, Shames DM, Wendland M, et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR Am J Roentgenol 1998; 171:941-949.
6. Brasch R, Turetschek K. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. Eur J Radiol 2000; 34:148-155.
7. Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999; 10:260-266.
8. Turetschek K, Huber S, Floyd E, et al. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. Radiology 2001; 218:562-569.
9. Runge VM. Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging 2000; 12:205-213.
10. Toth E, Helm L, Merbach AE. Relaxivity of gadolinium (III) complexes: theory and mechanism. In: Toth E, ed. The chemistry of contrast agents in medical magnetic resonance imaging. West Sussex, United Kingdom: Wiley, 2001; 45-119.
11. Henderson E, Sykes J, Drost D, Weinmann HJ, Rutt BK, Lee TY. Simultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents. J Magn Reson Imaging 2000; 12:991-1003.
12. Saini S, Sharma R, Baron RL, et al. Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging. Clin Radiol 2000; 55:690-695.
13. Bjornerud A, Johansson LO, Briley-Saebo K, Ahlstrom HK. Assessment of T1 and T2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state-dependence on blood volume and water exchange. Magn Reson Med 2002; 47:461-471.
14. Karczmar GS, Fan X, Al-Hallaq HA, et al. Uptake of a superparamagnetic contrast agent imaged by MR with high spectral and spatial resolution. Magn Reson Med 2000; 43:633-639.
15. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 1998; 40:793-799.
16. van Dijke CF, Brasch RC, Roberts TP, et al. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 1996; 198:813-818.
17. Turetschek K, Roberts TP, Floyd E, et al. Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model. J Magn Reson Imaging 2001; 13:882-888.
18. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 1984; 142:619-624.
19. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991; 15:621-628.
20. Niendorf HP, Haustein J, Cornelius I, Alhassan A, Clauss W. Safety of gadolinium-DTPA: extended clinical experience. Magn Reson Med 1991; 22:222-232.
21. Leiner T, Ho K, Ho V, Bongartz G, Mali W, Van Engelshoven JM. Multicenter trial of steady-state MR angiography of the peripheral arteries with NC100150 (Clariscan) for the evaluation of peripheral arterial disease (abstr). In: Proceedings of the Ninth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2001; 42.
22. Taylor AM, Panting JR, Keegan J, et al. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography. J Magn Reson Imaging 1999; 9:220-227.
23. Muller RN, Roch A, Colet JM, Ouakssim A, Gollis P. Particulate magnetic contrast agents. In: Toth E, ed. The chemistry of contrast agents in medical magnetic resonance imaging. West Sussex, United Kingdom: Wiley, 2001; 417-435.
24. Haacke M, Brown RW, Thompson MR, Venkatesan R. T1 estimation from SS1 measurements at multiple flip angles. In: Venkatesan R, ed. Magnetic resonance imaging: physical principles and sequence design. New York, NY: Wiley, 1999; 654-661.
25. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. I. Fundamental concepts. Magn Reson Med 1991; 17:357-367.
26. Tofts PS, Johnson G, Cha S. A simple model to characterize blood-brain barrier leakage from T2*-weighted bolus tracking MRI data (abstr). In: Proceedings of the Ninth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2001; 2242.
27. Zar JH. Comparing two correlation coefficients. In: Zar JH, ed. Biostatistical analysis. 3rd ed. Upper Saddle River, NJ: Prentice-Hall International, 1996; 375-382.
28. Hobbs SK, Monsky WL, Yuan F, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 1998; 95:4607-4612.
29. Kroft LJ, de Roos A. Blood pool contrast agents for cardiovascular MR imaging. J Magn Reson Imaging 1999; 10:395-403.
30. Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T(1)-weighted MRI. Magn Reson Med 2002; 47:601-606.
31. Port RE, Knopp MV, Brix G. Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors. Magn Reson Med 2001; 45:1030-1038.
32. Li KL, Zhu XP, Waterton J, Jackson A. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging 2000; 12:347-357.
33. Zhu XP, Li KL, Kamaly-Asl ID, et al. Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging. J Magn Reson Imaging 2000; 11:575-585.
34. Haacke M, Brown RW, Thompson MR, Venkatesan R. Magnetic properties of tissues: theory and measurement. In: Venkatesan R, ed. Magnetic resonance imaging: physical principles and sequence design. New York, NY: Wiley, 1999; 741-765.
35. Jain RK. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J Control Release 2001; 74:7-25.
36. Port RE, Knopp MV, Hoffmann U, Milker-Zabel S, Brix G. Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging. J Magn Reson Imaging 1999; 10:233-241.